Drug Database
Back to search

Netherlands· NL-bad94ae116e6

Respreeza

A alfa1 antitrypsin product containing alfa-1-proteinase inhibitor, humaan + alfa-1-proteinase inhibitor, humaan + alfa-1-proteinase inhibitor, humaan, registered in Netherlands by CSL Behring GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC B02AB02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRespreezaATCB02AB02REGISTER NO.NL-bad94ae116e6PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alfa-1-proteinase inhibitor, humaan + alfa-1-proteinase inhibitor, humaan + alfa-1-proteinase inhibitor, humaanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Alfa1 antitrypsin is registered in 11 of 19 countries.

Countries holding a registration under ATC B02AB02 (alfa1 antitrypsin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search alfa1 antitrypsin products by name

Alfa1 antitrypsin · ATC B02AB02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alfa1 antitrypsin costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Alfa1 antitrypsin · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • CH Switzerland$261.83
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ALFA-1-PROTEINASE INHIBITOR, HUMAAN + ALFA-1-PROTEINASE INHIBITOR, HUMAAN + ALFA-1-PROTEINASE INHIBITOR, HUMAAN
Manufacturer
CSL Behring GmbH
Country
Netherlands (NL)
ATC code
B02AB02
ATC class
Alfa1 antitrypsin
Defined daily dose
0.6 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/15/1006

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under B02AB02

Alfa1 antitrypsin, as other registers publish it.

All alfa1 antitrypsin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea341228-997e-4313-9743-54155c414522
GET /v1/drugs/ea341228-997e-4313-9743-54155c414522?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/respreeza-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Alfa1 Antitrypsin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp114783",
  "excipients": [
    "MANNITOL (D-) (E 421)",
    "MANNITOL (D-) (E 421)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMCHLORIDE",
    "NATRIUMCHLORIDE",
    "NATRIUMCHLORIDE",
    "NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
    "NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
    "NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)",
    "ZOUTZUUR (E 507)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "ALFA-1-PROTEINASE INHIBITOR, HUMAAN",
    "ALFA-1-PROTEINASE INHIBITOR, HUMAAN",
    "ALFA-1-PROTEINASE INHIBITOR, HUMAAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2015/08/20",
  "procedure_number": "EMEA/H/C/002739",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/15/1006",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about alfa1 antitrypsin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console